531739 — Gennex Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.11bn
- IN₹959.71m
- IN₹1.73bn
Annual cashflow statement for Gennex Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | C2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 52.8 | 63.7 | 165 | 214 | 233 |
| Depreciation | |||||
| Non-Cash Items | 17.8 | -13.1 | -7.19 | -47.8 | -29.4 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 40.7 | 177 | -648 | -269 | -867 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 119 | 237 | -467 | -95.6 | -637 |
| Capital Expenditures | -15.9 | -398 | 0 | -59.6 | -119 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -8.72 | 14.6 | 189 | 85.9 | 71.4 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -24.7 | -383 | 189 | 26.3 | -48 |
| Financing Cash Flow Items | -8.77 | -13.5 | -30.8 | -15.8 | -42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18.3 | 210 | 737 | 15.3 | 653 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 76.1 | 63.8 | 459 | -54 | -31.5 |